Canada - TSX-V:PHA - CA74052G1063 - Common Stock
The current stock price of PHA.CA is 0.025 CAD. In the past month the price decreased by -16.67%. In the past year, price decreased by -86.84%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL-DB.CA | WELL HEALTH TECHNOLOGIES | N/A | 25.50B | ||
| AND.CA | ANDLAUER HEALTHCARE GROUP IN | 34.28 | 2.09B | ||
| DNTL.CA | DENTALCORP HOLDINGS LTD | 26 | 2.09B | ||
| WELL.CA | WELL HEALTH TECHNOLOGIES COR | N/A | 1.32B | ||
| AIDX.CA | HEALWELL AI INC | N/A | 410.97M | ||
| NLH.CA | NOVA LEAP HEALTH CORP | N/A | 23.57M | ||
| NPTH.CA | NEUPATH HEALTH INC | N/A | 21.93M | ||
| ARC.CA | ARCPOINT INC | 0.67 | 2.57M | ||
| QIPT.CA | QUIPT HOME MEDICAL CORP | N/A | 155.67M |
Premier Health of America, Inc. engages in the provision of staffing and outsourced service solutions for healthcare needs. The company is headquartered in Blainville, Quebec. The company went IPO on 2018-12-24. The firm uses its proprietary LiPHe platform to lead the healthcare services sector digital transformation to provide patients with more accessible care services. The Company’s segments include Per Diem and Travel Nurses. The Per diem segment includes Placement Premier Soin and Code Bleu, two of its Quebec subsidiaries that offer their respective services for nursing and assistance by profile and by region. Per diem nurses work on an as-needed basis, sometimes for multiple health care institutions. The Travel Nurses segment includes Canadian Health Care Agency, Solution Staffing, Premier Health Nordik, and Solutions Nursing, four of its subsidiaries that offer their respective services to the federal and provincial governments for nursing and assistance, mostly in remote regions.
PREMIER HEALTH OF AMERICA IN
1114 Cure-Labelle Blvd., Suite 01
Blainville QUEBEC J7C 2M9 CA
CEO: Martin Legault
Employees: 555
Phone: 18002319916
Premier Health of America, Inc. engages in the provision of staffing and outsourced service solutions for healthcare needs. The company is headquartered in Blainville, Quebec. The company went IPO on 2018-12-24. The firm uses its proprietary LiPHe platform to lead the healthcare services sector digital transformation to provide patients with more accessible care services. The Company’s segments include Per Diem and Travel Nurses. The Per diem segment includes Placement Premier Soin and Code Bleu, two of its Quebec subsidiaries that offer their respective services for nursing and assistance by profile and by region. Per diem nurses work on an as-needed basis, sometimes for multiple health care institutions. The Travel Nurses segment includes Canadian Health Care Agency, Solution Staffing, Premier Health Nordik, and Solutions Nursing, four of its subsidiaries that offer their respective services to the federal and provincial governments for nursing and assistance, mostly in remote regions.
The current stock price of PHA.CA is 0.025 CAD.
PHA.CA does not pay a dividend.
PHA.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
PREMIER HEALTH OF AMERICA IN (PHA.CA) operates in the Health Care sector and the Health Care Providers & Services industry.
PREMIER HEALTH OF AMERICA IN (PHA.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.2).
The Revenue of PREMIER HEALTH OF AMERICA IN (PHA.CA) is expected to decline by -20.72% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a fundamental rating of 2 / 10 to PHA.CA. Both the profitability and financial health of PHA.CA have multiple concerns.
Over the last trailing twelve months PHA.CA reported a non-GAAP Earnings per Share(EPS) of -0.2. The EPS increased by 7.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -20.74% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
8 analysts have analysed PHA.CA and the average price target is 0.2 CAD. This implies a price increase of 716% is expected in the next year compared to the current price of 0.025.
For the next year, analysts expect an EPS growth of 40.21% and a revenue growth -20.72% for PHA.CA